Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
www.laserwelt.com
Laser World(translated to English)
can't wait to get some sales volume data but, even more excited to hear of the results, physician satisfaction, and usage rates from the independent clinical studies that are due short-term......
looking good VRSEF a solid hold or buy up to 1.25 before news on the independent clinical studies that prelude tells +++++
..... good luck to all!
ok...so things should be about to heat up. anyone think we'll see over a dollar before February?
Verisante = Finalist in Life Sciences
Awesome news!
http://www.photonicsprismaward.com/finalists.aspx
Latest Commercial Advertisement reputed to be airing on BNN(Business News Network: Canada's only all-business and financial news television channel.)
Doubt you have time to place orders on Stock for Verisante before close of market today. But apparently the sales blitz is about to begin based on the video evidence attached. Way to get into the market Verisante Technology Corporation!
http://www.globaltvcalgary.com/video/new+tool+cuts+down+on+biopsies/video.html?v=2293636665&p=1&s=dd#health+fyi
Wow Lared,
You are top notch on your analysis[sarcasm.] You must surely have noted that because the Canadian Skin Cancer Foundation has decided to put the Verisante Aura through the paces, that they must surely consider the corporation to be a total FLOP[READ EVEN MORE SARCASM PLEASE.]
Tell ya what, you recant your BS jargon and I'll recant my public accusation that you are likely a disgruntled investor in a potential competing medical device idk perhaps a company that has already been sued by its own shareholders for non-transparency, witholding relevant FDA approval notices to the company, and SEC violations......not going to name any names bc i consider the shareholders over there to be total choades but, we'll just leave it at that.
I guess I really shouldn't waste my time replying to your nonsense on this board because most who read this board and anyone who has done any due diligence regarding this market segment knows who you are likely rooting for regardless of the accuracy of the device or the functionality of the "life-or-death" medical device performance. I feel for your lack of ethics in investing and integrity as a human being but, at least the company you are rooting against, Verisante Technology Corporation, has both in leaps and bounds.
This company will prove itself in the future share value being higher, regardless of the nay-saying or the supporting verbage it gets from investors, who back Verisante like myself. In the end it will be simply the performance of its product suite and the satisfactory sales figures that will begin to be known soon enough.
I'm very excited to watch this play out and to know that those who have taken the time to research Verisante Technology Corp aren't remedial enough to fall for the ineptitude of jealous under-performing investors like yourself.
Though i wish you the best, i fear the worst for you relating directly to the utter malicious nature of your posting here.
I say good day!
Walt
Canadian Skin Cancer Foundation adopts the Verisante Aura!
Listen to the linked youtube audio clip to learn more.
http://www.youtube.com/embed/e9s_U2alQx0
DUDE he's getting an Aura! 18 second(s) ago
http://www.barrylyckamd.com/events.php
"play the audio - skip ahead to around the 4 minute mark. Just a short mention but good to hear. apparently a new more descriptive video will be up soon too on this. excited to see. just my thoughts." ElectricSockets stockhouse post Aug 6 2012
Having met the founder of the Canadian Skin Cancer Foundation personally at the AAD Annual Meeting 2012. I find this news remarkable. Having a leader in the field using the technology conveys the importance of adopting the technology.
It's a fantastic win for Verisante Technology Corp. and a big deal to be excited about. As good news like this continues to surface there is no turning back for Verisante. If this news hits the street level investors, the volume will surely pick-up even more of the headwinds that we saw from last month and continuing cordially. If volume goes viral as it likely will soon enough, hold onto your hats folks!
Good luck to all in the exciting sector of cancer diagnostics!
hkw
DUDE he's getting an Aura! 18 second(s) ago
http://www.barrylyckamd.com/events.php
"play the audio - skip ahead to around the 4 minute mark. Just a short mention but good to hear. apparently a new more descriptive video will be up soon too on this. excited to see. just my thoughts." ElectricSockets stockhouse post Aug 6 2012
Having met the founder of the Canadian Skin Cancer Foundation personally at the AAD Annual Meeting 2012. I find this news remarkable. Having a leader in the field using the technology conveys the importance of adopting the technology.
It's a fantastic win for Verisante Technology Corp. and a big deal to be excited about. As good news like this continues to surface there is no turning back for Verisante. If this news hits the street level investors, the volume will surely pick-up even more of the headwinds that we saw from last month and continuing cordially. If volume goes viral as it likely will soon enough, hold onto your hats folks!
Good luck to all in the exciting sector of cancer diagnostics!
hkw
DUDE he's getting an Aura! 18 second(s) ago
http://www.barrylyckamd.com/events.php
"play the audio - skip ahead to around the 4 minute mark. Just a short mention but good to hear. apparently a new more descriptive video will be up soon too on this. excited to see. just my thoughts." ElectricSockets stockhouse post Aug 6 2012
Having met the founder of the Canadian Skin Cancer Foundation personally at the AAD Annual Meeting 2012. I find this news remarkable. Having a leader in the field using the technology conveys the importance of adopting the technology.
It's a fantastic win for Verisante Technology Corp. and a big deal to be excited about. As good news like this continues to surface there is no turning back for Verisante. If this news hits the street level investors, the volume will surely pick-up even more of the headwinds that we saw from last month and continuing cordially. If volume goes viral as it likely will soon enough, hold onto your hats folks!
Good luck to all in the exciting sector of cancer diagnostics!
hkw
the markets are in blaaaaahhhhhh....................
BRACE YOURSELVES.......unless there is some larger "manipulator" puppetting the value and involved in this financing equation, with the volume fall-off now, there should reasonably be a price up-tick in response to fewer shares "for sale" by the holders.
Verisante is overdue and vastly undervalued at this point. Everyone, with few exceptions who has done significant research in this segment, is well aware. LOOK AT THE MARKET SEGMENT. When compared with the competition, having a 25x larger potential market for these devices, detecting not only melanoma but also the other 96% of skin cancers, consuming a fraction of the time 1 second vs. 2 minute scan time, and costing a fraction of the per-use-price for MD end-users $50 scan vs. $10/per disposable tip; Verisante brings only one word to mind.
SUPREMECY only becomes more well established with each news release. further, with the current securities lawsuit faced by the nearest competitor in this sector, having two, not 1 but count 'em 2-securities attorneys at the helm for Verisante is no laughing matter unless, of course, you take stock in VRS-canada/VRSEF-usa/V3T-germany.
LOVING IT,
Walt
BRACE YOURSELVES.......unless there is some larger"manipulator" involved in this financing equation, with the volume fall-off now, there should reasonably be a price up-tick in response to fewer shares "for sale" by the holders.
we are overdue and vastly undervalued at this point. everyone with few exceptions who has done significant research in this segment is well aware. and what with having a 25x larger potential market for these devices(detecting not only melanoma but also the other 96% of skin cancers) when compared with the competition and in a fraction of the time 1 second vs. 2 minutes and fraction of the per-use-cost to the MD end-user $50/2minute scan vs. $10/per disposable tip.
supremecy only becomes more well established with each news release and with the current securities lawsuit faced by the competitors in this sector, having to securities attorneys at the helm for Verisante is no laughing matter unless you take stock in VRS-canada/VRSEF-usa/V3T-germany
LOVING IT,
Walt
Tech Industry Remains at the Top of the Global Trust Barometer for 6th Year
Posted on February 29, 2012 by Thomas
79% of respondents to an annual global trust survey said that they trust the technology industry which was the highest of any industry. The banking and financial sector were at the bottom again with 45% of respondents willing to trust them.
The survey was conducted by StrategyOne for Edelman. The 20 minute online survey sampled 30,600 people in 25 countries.
I believe that the public trust the technology sector as a whole due to their faith in science and technology in general to solve problems. What I hear from skin cancer patients is that they would like to have an objective scientific method to detect skin cancer for peace of mind.
The Aura takes a scientific measurement in less than one second – turning what has traditionally been an art into a science. Instead of basing the biopsy decision on the subjective ABCD method, with the Aura, doctors will be able to base their biopsy decision on an objective measurement.
No wonder skin cancer patients are anxiously awaiting the Aura.
http://verisante.com/blog/
A new video is highlighting Verisante's current events and key concepts of the Aura.
That FDA bit jives with what I've been smelling in the winds.
You make the best posts Michael! Concise, to the point, and your ideas here on Verisante seem dead-on the money. So, true about the need to market the device. It's amazing watching med Technology progress through the years. This device shall likely be of little difference when compared in hindsight.
I'm glad with this stock, that we'll have hindsight in our corner when the chips fall.
Doctors- another thing worth noting
After re-reading the post here by davidde, i felt that he may not necesarily be a "poser" although i obviously have lingering doubts.It is entirely possible he may simply be one of those people who have an extremely high regard for every word that exits a doctors mouth. Perhaps an even higher regard than other doctors would have for those same words.
The article below may help to highlight something for those like him that may not be privy to just why doctors love using tools like AURA that aid them in making accurate diagnosis at the bedside. Surgeons probably use more tools than other doctors. They are also reputed to be some of the more honest. Cardiologists come to mind as some of the best paid and most highly regarded as honest doctors.
The following article may help you to see this scenario in another perspective as well.
http://www.sacbee.com/2012/02/08/4249439/many-doctors-hide-the-truth-about.html#disqus_thread
Most Famous Melanoma Victim?
Bob Marley would be 67 today? This is what I've just stumbled upon whilst doing an obligatory "verisante past 24 hours google search."
There is a quite nice article that points out the past constrants of FDA requirements for a device designed for melanoma deteciton. It really highlights the obvious glaring successes in this theatre by BCC and Verisante with direct respect for the Aura! Very poignant. And very nice for everyone except perhaps the late market "exitters." I feel sorry for "what's his name" who's decided to "sit out" on this BioTech Marvel!
Article link!
http://features.rr.com/article/04Fo8h2eBs1OA?q=Skin+Cancer
reposted from another Verisante discussion Forum
the battle will be won by the biopsy ratios
doctors 200:1 for all cancerous lesions cited by Verisante (200 biopsies for every 1 skin cancer diagnosis)
dermatologists 50:1 for melanoma cited by Mela Sciences
VERISANTE AURA - 1.03:1 - so this means 1.03 biopsies for every real cancer diagnosis - people this is stunning!
MELA FIND: 7.6:1 -7.6 Biopsies for every 1 successful melanoma diagnosis
PEOPLE - think about this; the study for Verisante's AURA still has not been published by the scientific journal - the company has to be very careful as to what they say publicly until this paper is published as saying anything or promoting the results of the paper prior to the specific scientific journals publication would be in direct violation of the publication agreement and would directly threaten the process. Go ahead and call the company to verify this.
Early investors are very lucky that Professor Zeng was invited for the SPIE conference in January -giving us a tiny peek into the (in my opinion) stellar results of this study.
In my best guess - once this longly anticipated paper is published - company promotion will be through the roof - think about it.
Everything to me seems ready to go - it is just the formalities of publishing a peer-reviewed scientific paper - an antiquated and slow process that needs to be this way - it just doesn't bode well for impatient investors.
tick tick tick....we are getting closer.
What will Verisante's biopsy ratio be for melanoma?
How were the statistic's calculated and how does this compare to the Melafind study?
Only my well researched thoughts. Please do your own due diligence.
--my thoughts--
While observing the SPIE presentation, that was one of those moments where it clicked for me. The biopsy ratios really highlighted a marked improvement over the past methods of skin cancer diagnosis. I wait anxiously for the next report on FDA status. = ] hkwalt
wrong board for Jerkio.....ROFL...nice name though.
my understanding is that they're not yet taking orders.... if you read a few posts back there was a status update. it talks about how they're going to be doing production in the middle of 2012....although it's a safe bet that 10 units already have been manufactured at the Starfish facility. also a safe bet that after advisory to verasante by FDA that the 10 units will go to do further clinical testing if guided by the FDA to do so. otherwise, it's possible that those would be demonstration units for sales staff.
if there was a gun pointed in your direction and you were given the opportunity to peg your entire retirement holdings to one Medical/Technology company below a dollar, which one would you choose?
if you had to peg your retirement holdings to one Medical/Technology company below a dollar, which one would you choose?
the market is going to be so "sick" over itself....when those 10 Auras hit the ground and the airwaves....i do concur with what i've read from someone elsewhere and that is they will definitely create buzz.
buzz will help greatly with marketing/sales...
when those 10 hit the ground running, they will really "Glam" up the scene and the SP should heartily eat the benefits in a big way....
SO EXCITED FOR THIS COMPANY AND ALL THOSE WILLING TO VENTURE INTO THE REALM OF THE HIGHEST TIER OF THE OTC MARKET! THIS STOCK WILL BE LOOKED BACK UPON AS A POSTER CHILD FOR THE OTC QX EXCHANGE IN THE U.S.
For those unable to attend Photonics West today and hear Dr. Zeng's presented "by invitation" paper, it was well received. Solid data and a very stand-up instructor by my estimation as well as some of the other industry experts in attendance.
Seeing his solid stance and command of the data as well as his confidence in general really shores-up my continued positive rating of the VRSEF stock.
Rating: BUY with a vengeance!
Real-time Raman spectroscopy for in vivo evaluation of skin cancers (Invited Paper)
Paper 8207A-27
Time: 11:30 AM - 11:55 AM
Author(s): Jianhua Zhao, Haishan Zeng, The BC Cancer Agency Research Ctr. (Canada) and The Univ. of British Columbia (Canada); David I. McLean M.D., Harvey Lui M.D., The Univ. of British Columbia (Canada) and The BC Cancer Agency Research Ctr. (Canada)
Hide Abstract Add to My Schedule
An integrated real-time Raman spectroscopic system was constructed for in vivo skin cancer diagnosis. Multi-variant statistical data analysis including principal component analysis (PCA), general discriminant analysis (GDA), and partial least squares (PLS) were used for lesion classification. The analyses were divided into three classifications based on clinical interest: (1) to discriminate skin cancers and precancers from benign skin lesions; (2) to discriminate malignant melanoma from non-melanoma pigmented lesions; and (3) to discriminate malignant melanoma from seborrheic keratosis. Our results demonstrated that real-time Raman spectroscopy is a very promising technique for in vivo clinical skin cancer diagnosis.
http://spie.org/app/program/index.cfm?fuseaction=conferencedetail&conference_id=960833&event_id=896186&list=1&abstracts=1
Benefits of publishing with SPIE
Publication of your manuscript on SPIE Digital Library offers worldwide access within 2 to 4 weeks after the meeting With over 300,000 papers covering 1990 to the present, SPIE Digital Library is the world's largest collection of research papers in optics and photonics Proceedings of SPIE are among the most cited references in the patent literature SPIE partners with relevant scientific databases to enable researchers to find the papers in the Proceedings of SPIE easily. The databases that abstract and index these papers include Astrophysical Data System (ADS), Chemical Abstracts (relevant content), Compendex, CrossRef, Current Contents, DeepDyve, Google Scholar, Inspec, Portico, Scopus, SPIN, and Web of Science Conference Proceedings Citation Index. Articles and citations are linked via CrossRef Publish your manuscript with attached multimedia files in SPIE Digital Library After publication in Proceedings of SPIE, expand and revise your paper and submit it to one of SPIE's peer-reviewed journals (http://spie.org/journals ).
http://spie.org/x27472.xml
OK. NOW WE'RE TALKIN'. look at the support volume at the new pricing. NICE day for backing up the gains of yesterday.
i believe the gentleman is referring to the individual "modlshp" and would like to know when he changed his name.
perhaps, "modlshp" posed the same inquiry on the forum as another person with a different name? that's my take on his meaning....any other meaning borders on irrelevance.
My understanding is that this particular study awaits "peer review." In other words, once an entity confirms the study process/data, it shall be published to some scholarly journal and thus made "public."
http://thetradersdigest.blogspot.com/
at the bottom of the page is a nice "slide" presentation about the key aspects of Verisante..... pretty neat
I'm reckoning that the "ask" price offerings eg. current .69/share for 2500 share blocks will be the price drivers aka actual trades should be on that side tentatively......
That's being optimistic that the street-level share holders are lucky enough to be in a position to hold on for the ride up.......
I just hope that the small guys(similar to myself not being a warrant holder) are wise enough and lucky enough to have time on their hands. In so much as they will be able to ask higher share prices in smaller share offerings eg. .71/share for 500 shares....so as to take out some cash and not impede the advance of the of Verisante share price.....
If we educate other individual traders on pricing appropriately by placing limits as we are allowed to do eg. with my Scottrade.com account; would this not in turn assist with limiting derogatory price competition with large volume share holders like the warrant keepers during divestment transactions, can we not help present the most accurate and reasonable value of the SP by such promotion this practice.
your thoughts appreciated here.....also, i'm probably going to get out and see a bit of the day light if i don't just get right back to you that's what is up.....not ignoring
VRSEF gains +6.o4% at open of USotcQx for first trade of 2012.
Year of the Dragon to be "great one" for Verisante?
Who knew?
Happy New Year!
yep....it would probably rise to the ceiling in terms of Share price given what all the milestones have garnered
wouldn't that be awful!
wow starmaned.... >=-] you almost sounded sincere in your statement......?
Not only is it in but it is "automatically" included aka approved to the "ARTG -Australian Register of Therapeutic Goods."
Note on that link the "START DATE" of 16 December 2011
as well as the "STATUS" is Active
meaning it is included on the "register"
FANTASTIC PERFORMANCE FROM A GREAT
MEDICAL TECHNOLOGY NEW COMER
the catchphrase on the canadian board stockhouse.com seems to be that "this is tax loss selling season". will continue at least thru the 27th if what "they" say is accurate......
we shall see.